Director/PDMR Shareholding

RNS Number : 3402Y

Barclays PLC

20 February 2013

 



20 February 2013 

Barclays PLC

("the Company")

Director/PDMR shareholding: Disclosure and Transparency Rules 3.1.4R (1) (a)

On 19 February 2013 the following ordinary shares in Barclays PLC ("the Company") were purchased on the London Stock Exchange on behalf of the Chairman and the non-executive Directors of the Company at a price of £3.24009 per share.  These purchases arise from the policy of using part of fee payable to each such Director to purchase shares in the Company, which, together with any reinvested dividends, are retained for the Director until they leave the Board.

DIRECTOR	BARCLAYS PLC SHARES PURCHASED	TOTAL BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION	TOTAL NON-BENEFICIAL INTEREST FOLLOWING THIS NOTIFICATION
David Booth	2,489	94,550	-
Tim Breedon	655	2,655	-
Fulvio Conti	2,963	60,978	-
Simon Fraser	2,667	90,637	-
Reuben Jeffery¹	3,680	128,148	-
Sir Andrew Likierman	2,515	42,835	-
Dambisa Moyo	2,666	19,232	-
Sir Michael Rake	2,386	45,211	-
Sir John Sunderland	2,487	98,302	-
Sir David Walker	4,601	81,904	-

¹ Reuben Jeffery's beneficial interest comprises 25,000 American Depositary Shares and 28,148 Ordinary Shares in Barclays PLC

 

END

 

 

RDSPGUBUPUPWGMU